INSIDE THE REAL'S MIND

​

Body Dysmorphic Disorder (BDD) is a severe, often hidden condition defined by a distressing preoccupation with perceived defects in appearance and by repetitive, appearance-focused behaviors that impair daily functioning (Phillips, 2010; NICE, 2005/2024 review).  BDD is conceptually placed on the obsessive–compulsive spectrum and includes a specifier—muscle dysmorphia—in which individuals (often males) are convinced they are insufficiently muscular despite objective evidence to the contrary (Murray et al., 2010; Sandgren & Lavallee, 2018). 

Across population studies, point-prevalence is typically estimated around 0.5–3.2%, with markedly higher rates reported in cosmetic settings (McGrath et al., 2023; Phillips, 2021).  In cosmetic surgery and dermatology clinics, pooled prevalence has been estimated at ~13% overall and ~20% in rhinoplasty cohorts (Phillips, 2021). 

​

Why BDD Deserves Clinical Priority

​

BDD is associated with substantial morbidity and suicidality. A seminal review and a prospective cohort by Phillips and colleagues found lifetime suicidal ideation in ~80% and suicide attempts in 24–28%, with elevated annualized attempt rates in longitudinal follow-up; a meta-analysis confirms suicidality is strongly linked to BDD (Phillips, 2006; Phillips, 2007; Angelakis et al., 2016). The disorder also co-occurs with depressive and anxiety disorders, as well as OCD-spectrum features, and typically begins in adolescence—complicating early identification and help-seeking (Phillips, 2010; NICE, 2005/2024 review). 

​

Perfectionism: From “High Standards” to Clinical Risk

​

Perfectionism—especially the maladaptive form characterized by self-criticism, doubts about actions, and an overemphasis on error—appears to be a central psychological risk and maintenance factor in BDD. Laboratory and clinical studies show individuals with BDD endorse significantly higher perfectionistic thinking than controls or even those with OCD (Buhlmann et al., 2008). In adolescents, self-oriented perfectionism prospectively predicts BDD symptoms over six months, even after controlling for anxiety and depression (Krebs et al., 2019).  Recent work also implicates multidimensional perfectionism (e.g., concern over mistakes, socially prescribed perfectionism) in predicting dysmorphic and symmetry concerns (Toh et al., 2022). 

Digital Amplifiers: Social Media & Appearance Comparison

Systematic reviews and primary studies indicate that image-based social media use and appearance-focused motives are positively associated with dysmorphic symptoms; perfectionism can amplify these links (Gupta et al., 2023; Ateq et al., 2024; Ryding & Kuss, 2020).  The mechanism aligns with BDD cognitive models: perfectionistic self-standards, selective attention to “flaws,” and repeated checking/avoidance behaviors generate a self-reinforcing loop of defect-focused attention and distress (Phillips, 2010; Wilhelm et al., 2013/2014). 

​

Cosmetic Procedures: Why Outcomes Are Commonly Poor in BDD

​

A consistent finding across plastic surgery and dermatology is that cosmetic intervention rarely resolves BDD and can worsen symptoms by shifting preoccupation to new “defects.” Systematic and critical reviews conclude that outcomes in BDD are generally unsatisfactory, with symptom exacerbation reported (Crerand et al., 2010; Bowyer et al., 2016).  Surveys of surgeons echo this risk: most clinicians who recognized BDD in their patients reported poor postoperative outcomes, yet many did not view BDD as an absolute contraindication—highlighting the need for better screening and referral (Sarwer et al., 2002). 

Practical Red Flags in Aesthetic Contexts

• Rigid perfectionistic standards (e.g., “If it isn’t perfect, it’s a failure”) and hours of checking/camouflaging.

• Narrow, non-negotiable goals (e.g., an exact nose angle in millimeters).

• History of multiple procedures with persistent or shifting dissatisfaction.
  These features should prompt screening and mental-health referral before any elective procedure (NICE, 2005/2024 review; Phillips, 2021). 

​

​

Assessment & Measurement

​

The BDD-YBOCS is the standard clinician-rated instrument for BDD severity and change over time; it shows strong psychometric properties and sensitivity to treatment effects (Phillips et al., 1997; Phillips et al., 2001). 

​

What Helps: Evidence-Based Treatments

​

Cognitive-Behavioural Therapy for BDD (CBT-BDD)

CBT-BDD targets perfectionistic appearance beliefs, selective attention to perceived flaws, safety behaviors (e.g., mirror checking, skin picking), and avoidance. Protocols include exposure with response prevention, mirror retraining, perceptual retraining, and cognitive restructuring (Wilhelm et al., 2013/2014). Randomized trials—including therapist-guided and internet-based CBT (BDD-NET)—demonstrate clinically significant symptom reductions and durable gains (Wilhelm et al., 2014; Enander et al., 2016; Blashill et al., 2020).  Recent analyses suggest many patients respond within ~19–21 weeks of structured CBT-BDD (Hoeppner et al., 2023). 

​

Pharmacotherapy

SSRIs/SRIs have the strongest pharmacological evidence. A randomized, placebo-controlled trial showed fluoxetine superior to placebo with ~53% response (Phillips et al., 2002); clomipramine outperformed desipramine in an earlier crossover trial (Hollander et al., 1999).  Review syntheses confirm SSRI efficacy, including among individuals with poor insight/delusional intensity (Phillips, 2010; Castle et al., 2021).  Guidelines recommend CBT-BDD and/or SSRIs as first-line, with stepped care based on severity and comorbidity . 

​

Adjunctive Targets

​

Because low self-esteem and shame frequently co-occur with BDD, targeted interventions on self-esteem and self-compassion may add value; emerging controlled work shows promise for brief, internet-based self-esteem training in adults with dysmorphic symptoms (Kuck et al., 2021; Bosbach et al., 2024; Foroughi et al., 2019). 

​

Where Perfectionism Fits in Treatment

​

CBT-BDD directly de-centers perfectionistic standards by testing feared outcomes (e.g., tolerating “imperfection” in appearance without safety behaviors) and re-weighting values beyond appearance. In youth, explicitly addressing self-oriented perfectionism may improve outcomes, given its prospective link to dysmorphic symptoms (Krebs et al., 2019). 

​

Ethical Implications for Clinics and Marketers

​

Given elevated BDD rates in cosmetic settings and the poor procedural outcomes observed among BDD patients, ethical practice requires:

1. Screening for BDD indicators (history of procedures with persistent dissatisfaction; extreme perfectionism; time-consuming preoccupations).

2. Informed referral to CBT-BDD/SSRIs rather than “selling” corrective procedures.

3. Avoiding manipulative urgency or appearance-perfection messaging that can aggravate BDD/perfectionism dynamics.
   These steps align with best-evidence syntheses and protect both patients and clinic reputation (Crerand et al., 2010; Bowyer et al., 2016). 

​

Practical Takeaways for Readers

​

• If you’re chasing the “perfect” fix and your goals narrow to millimetres, pause and seek a specialist assessment; BDD is treatable and treatment—not surgery—addresses the root drivers. ( Wilhelm et al., 2014). 

• Track time spent checking, camouflaging, or comparing looks; hours per day of preoccupation is a red flag (Phillips et al., 1997/2001). 

• Ask clinics about screening and referral pathways before paying any deposit—ethically mature teams should have them (Sarwer et al., 2002; Phillips, 2021). 

​

Disclaimer: Educational content. Not a substitute for medical advice. If you recognize yourself in this article, seek evaluation from a clinician experienced in BDD.

​

References 

​

Angelakis, I., Gooding, P., & Panagioti, M. (2016) ‘Suicidality in body dysmorphic disorder (BDD): A systematic review and meta-analysis’, Clinical Psychology Review, 49, pp. 55–66. (ScienceDirect)

Ateq, K., Alshamrani, A., et al. (2024) ‘The association between use of social media and body dysmorphic disorder’, Frontiers in Public Health, 12, 1324092. (PMC)

Blashill, A.J. et al. (2020) ‘Psychiatric and functional outcomes following CBT for BDD’, PLoS ONE, 15(8): e0237651. (cited within RCT context). (PubMed)

Bosbach, K. et al. (2024) ‘Enhancing self-esteem in adults with body dysmorphic symptoms: Initial evaluation of a brief internet-based training’, Behavioural and Cognitive Psychotherapy. (Cambridge University Press & Assessment)

Bowyer, L. et al. (2016) ‘A critical review of cosmetic treatment outcomes in body dysmorphic disorder’, Body Image, 19, pp. 1–8. (ScienceDirect, King's College London)

Buhlmann, U., Etcoff, N.L., & Wilhelm, S. (2008) ‘Facial attractiveness ratings and perfectionism in BDD and OCD’, Journal of Anxiety Disorders, 22(3), pp. 540–547. (ScienceDirect)

Castle, D. et al. (2021) ‘Body dysmorphic disorder: A treatment synthesis and consensus update’, International Clinical Psychopharmacology, 36(2), pp. 61–75. (Lippincott Journals)

Crerand, C.E., Menard, W., & Phillips, K.A. (2010) ‘Surgical and minimally invasive cosmetic procedures in patients with body dysmorphic disorder’, Annals of Plastic Surgery, 65(1), pp. 11–16. (PMC)

Enander, J. et al. (2016) ‘Therapist-guided internet-based CBT for body dysmorphic disorder: Single-blind randomised controlled trial’, BMJ, 352, i241. (PubMed)

Foroughi, A. et al. (2019) ‘External shame, perfectionism, self-compassion and dysmorphic concern’, Iranian Journal of Psychiatry and Behavioral Sciences, 13(3), e80186. (Brieflands)

Hollander, E. et al. (1999) ‘Clomipramine vs desipramine in body dysmorphic disorder’, Archives of General Psychiatry, 56(11), pp. 1033–1039. (JAMA Network)

Hoeppner, S.S. et al. (2023) ‘Time to response in therapy for body dysmorphic disorder’, CNS Spectrums, 28(5), pp. 600–609. (PMC)

Krebs, G. et al. (2019) ‘Is perfectionism a risk factor for adolescent BDD? A prospective study’, Journal of Obsessive-Compulsive and Related Disorders, 22, 100447. (PMC)

Kuck, N. et al. (2021) ‘Body dysmorphic disorder and self-esteem: A meta-analysis’, European Psychiatry, 64(1), e56. (PMC)

McGrath, L.R. et al. (2023) ‘Prevalence of body dysmorphic disorder: A systematic review’, Body Image, 47, pp. 64–79. (ScienceDirect)

Murray, S.B., Rieger, E., Touyz, S.W., & De la Garza Garcia Lyne, J. (2010) ‘Muscle dysmorphia and the DSM-V conundrum’, Journal of Clinical Psychology in Medical Settings, 17(4), pp. 467–474. (PubMed)

NICE (2005, last reviewed 2024) Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31). London: National Institute for Health and Care Excellence. (NICE)

Phillips, K.A. (2010) ‘Body Dysmorphic Disorder: Some key issues for DSM-V’, Depression and Anxiety, 27(6), pp. 573–591. (PMC)

Phillips, K.A. (2021) ‘Body dysmorphic disorder: Clinical overview and current treatments’, Focus (Am Psychiatr Publ), 19(2), pp. 190–204. (PMC)

Phillips, K.A. et al. (1997) ‘A severity rating scale for BDD: Development, reliability, and validity of the BDD-YBOCS’, Psychopharmacology Bulletin, 33, pp. 17–22. (PubMed)

Phillips, K.A. et al. (2001) ‘Psychometric evaluation of the BDD-YBOCS’, Primary Psychiatry, 8(12), pp. 58–66. (PMC)

Phillips, K.A. et al. (2002) ‘A randomized, placebo-controlled trial of fluoxetine in body dysmorphic disorder’, Archives of General Psychiatry, 59(4), pp. 381–388. (PubMed)

Phillips, K.A. (2006/2007) ‘Suicidality in body dysmorphic disorder’, American Journal of Psychiatry; Psychiatric Clinics Review (review & prospective data). (Psychiatry Online, PMC)

Ryding, F.C. & Kuss, D.J. (2020) ‘Social networking sites, body image dissatisfaction and BDD: A systematic review’, Psychology of Popular Media, 9(4), pp. 412–435. (Cited within 2025 Frontiers review). (Frontiers)

Sandgren, S.S. & Lavallee, D. (2018) ‘Muscle dysmorphia research and DSM-5 diagnostic criteria: A systematic review’, Psychology of Sport and Exercise. (Abertay University)

Sarwer, D.B., Wadden, T.A., & Pertschuk, M.J. (2002) ‘Awareness and identification of BDD by cosmetic surgeons’, Aesthetic Surgery Journal, 22(6), pp. 531–535. (Oxford Academic)

Toh, W.L. et al. (2022) ‘Multidimensional perfectionism and dysmorphic concerns’, Psychiatry Research Reports, 1(1), 100014. (ScienceDirect)

Wilhelm, S., Phillips, K.A., & Steketee, G. (2013) Cognitive-Behavioral Therapy for Body Dysmorphic Disorder: A Treatment Manual. (Key elements summarized in RCTs). (PMC)

Wilhelm, S. et al. (2014) ‘Modular CBT for BDD: A randomized controlled trial’, Behaviour Therapy, 45(3), pp. 314–327. (PubMed)